Cargando…
Pharmaceutical Perspectives of Cancer Therapeutics
Pharmaceutical Perspectives of Cancer Therapeutics presents a comprehensive yet easy-to-follow review of the principles, current progress and state-of-the-art of cancer therapeutics. The complexity of cancer demands an integrated understanding from both cancer biology and pharmaceutical dosage forms...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2009.
|
| Edición: | 1st ed. 2009. |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-1-4419-0131-6 | ||
| 003 | DE-He213 | ||
| 005 | 20220117032443.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2009 xxu| s |||| 0|eng d | ||
| 020 | |a 9781441901316 |9 978-1-4419-0131-6 | ||
| 024 | 7 | |a 10.1007/978-1-4419-0131-6 |2 doi | |
| 050 | 4 | |a RC261-271 | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 072 | 7 | |a MED062000 |2 bisacsh | |
| 072 | 7 | |a MJCL |2 thema | |
| 082 | 0 | 4 | |a 571.978 |2 23 |
| 082 | 0 | 4 | |a 616.994 |2 23 |
| 245 | 1 | 0 | |a Pharmaceutical Perspectives of Cancer Therapeutics |h [electronic resource] / |c edited by Yi Lu, Ram I. Mahato. |
| 250 | |a 1st ed. 2009. | ||
| 264 | 1 | |a New York, NY : |b Springer New York : |b Imprint: Springer, |c 2009. | |
| 300 | |a XVI, 694 p. 31 illus., 19 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Tumor Microvasculature and Microenvironment: Therapeutic Targets for Inhibition of Tumor Angiogenesis and Metastasis -- Anticancer Drug Development -- Tumor-Targeted Macromolecular Drug Delivery Based on the Enhanced Permeability and Retention Effect in Solid Tumor -- Multidrug Resistance in Solid Tumor and Its Reversal -- Targeting of Apoptosis Signaling Pathways and Their Mediators for Cancer Therapy -- Role of Telomerase in Cancer Therapeutics -- Polymeric Carriers for Anticancer Drugs -- Application of Nanobiotechnology in Cancer Therapeutics -- Receptor-Mediated Delivery of Proteins and Peptides to Tumors -- Protein Transduction Domain-Mediated Delivery of Anticancer Proteins -- Pharmaceutical Perspectives of Cancer Therapeutics: Current Therapeutic Uses of Monoclonal Antibodies -- Cancer Vaccines -- RNA Interference for Cancer Therapy -- MicroRNAs as Therapeutic Targets for Cancer -- Targeted Therapies for Malignant Brain Tumors -- The Complexity of the HIF-1-Dependent Hypoxic Response in Breast Cancer Presents Multiple Avenues for Therapeutic Intervention -- Cancer Stem Cells: Potential Mediators of Therapeutic Resistance and Novel Targets of Anti-cancer Treatments -- Image-Guided Photodynamic Cancer Therapy -- Functional Imaging of Multidrug Resistance and Its Applications -- Gene Expression Microarrays in Cancer Research -- Clinical Trials and Translational Applications in Cancer Therapy. | |
| 520 | |a Pharmaceutical Perspectives of Cancer Therapeutics presents a comprehensive yet easy-to-follow review of the principles, current progress and state-of-the-art of cancer therapeutics. The complexity of cancer demands an integrated understanding from both cancer biology and pharmaceutical dosage forms and drug delivery in order to warrant a successful therapeutic regimen. This book combines and merges the knowledge from these two aspects. Internationally acclaimed experts with a multi-disciplinary background, including scientists and clinicians from both academia and industries have contributed to this book to bridge the following areas between basic research and clinical application, pharmaceutical drug development processes and regulatory issues, drug design and delivery, laboratory and translational experimentation, marketing and postmarketing surveillance. Main features of the book: Anticancer drug development and regulatory processes. Strategies to suppress tumor angiogenesis and metastasis, overcome multi-drug resistance in cancer, target telomerase and apoptosis pathways. Therapeutic approaches to employ monoclonal antibody and cancer vaccines. Introduction of new concepts such as cancer stem cells and new technologies such as nanobiotechnology, RNA interference, microRNA, and cancer cell gene profiling. Use of lipids, polymers and peptides for drug delivery and targeting to cancer cells or specific organs. Utilization of bioimaging and HIF-1 knockout animal models in cancer study. Clinical trials designs and principles. | ||
| 650 | 0 | |a Cancer. | |
| 650 | 1 | 4 | |a Cancer Biology. |
| 700 | 1 | |a Lu, Yi. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Mahato, Ram I. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9781441901323 |
| 776 | 0 | 8 | |i Printed edition: |z 9781441901309 |
| 776 | 0 | 8 | |i Printed edition: |z 9781493939565 |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/978-1-4419-0131-6 |z Texto Completo |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||